B O O K - American College of Rheumatology

ACR/ARHP Poster Session B
967. Fracture Incidence, Quality of Life and Back Pain in Women
with Osteoporosis and Concomitant Glucocorticoid Use
Treated with Teriparatide: 36 Month Results from the
European Forsteo Observational Study (EFOS). Willem Lems 9 ,
Bente Langdahl 6 , Osten Ljunggren 7 , Annabel Barrett 2 , Dimitrios
Karras 8 , James Bernard Walsh 4 , Astrid Fahrleitner-Pammer 3 ,
Gerald Rajzbaum 5 , Clare Barker 2 , Franz Jakob 1 and Fernando
Marin 2 , 1 Julius-Maximilians-Univ, Würzburg, Germany, 2 Lilly
Research Ctr., Windlesham, UK, 3 Med Univ, Graz, Austria, 4 St
James’s Hosp Trinity College, Dublin, Ireland, 5 St Joseph Hosp,
Paris, France, 6 Univ Hosp, århus, Denmark, 7 Univ Hosp, Uppsala,
Sweden, 8 Veterans Admin Hosp, Athens, Greece, 9 VU Univ Hosp,
Amsterdam, Netherlands.
968. Fracture Risk Assessment and Osteoporosis Treatment
Disparities in 4027 Japanese Patients with Rheumatoid
Arthritis. Takefumi Furuya 2 , Takayuki Hosoi 1 , Eisuke Inoue 3 ,
Atuo Taniguchi 3 , Shigeki Momohara 3 and Hisashi Yamanaka 4 ,
1
Department of Clinical Research and Development,
National Center for Geriatrics and Gerontology, 2 Institute of
Rheumatology, Tokyo Women’s Medical University, Tokyo,
Japan, 3 Institute of Rheumatology, Tokyo Women’s Medical
University, 4 Tokyo Women’s Medical University, Shinjuku-ku,
Tokyo, Japan.
969. Health Care Utilization Following a Fracture: Global
Longitudinal Study of Osteoporosis in Women (GLOW).
George Ioannidis 3 , Jonathan D. Adachi 2 , Laura Pickard 3 , Roland
Chapurlat 4 , Kenneth G. Saag 5 , Stuart L. Silverman 1 , Julie Flahive 6
and Stephen Gehlbach 6 , 1 Cedars-Sinai Medical Center, University
of California Los Angeles, Beverly Hills, CA, 2 McMaster
University, Hamilton, ON, Canada, 3 McMaster University,
4
Universite de Lyon, 5 University of Alabama-Birmingham,
Birmingham, AL, 6 University of Massachusetts.
970. High Adherence with Bisphosphonate Therapy in US Veterans
with Rheumatoid Arthritis. J. Steuart Richards 10 , Grant W.
Cannon 9 , Candace L. Hayden 8 , Richard L. Amdur 11 , Ted R.
Mikuls 6 , Andreas Reimold 2 , Liron Caplan 3 , Dannette S. Johnson 5 ,
Pascale Schwab 7 , Deana Lazaro 1 , Bogdan N. Cherascu 4 and Gail
S. Kerr 11 , 1 Brooklyn NY VA Medical Center, New York, NY, 2 Dallas
TX VA Medical Center, Dallas, TX, 3 Denver CO VA Medical Center,
Denver, CO, 4 Iowa City IA VA Medical Center, Iowa City, 5 Jackson
MS VA Medical Center, Jackson, MS, 6 Omaha NE VA Medical
Center, Omaha, NE, 7 Portland OR VA Medical Center, Portland,
OR, 8 Salt Lake City UT VA Medical Center, Salt Lake City, UT, 9 Salt
Lake City VA Medical Center, Salt Lake City, UT, 10 Washington
DC VA Medical Cener, Washington, DC, 11 Washington DC VA
Medical Center, Washington, DC.
971. Impact of Incident Clinical Vertebral Fractures on Back Pain
Outcomes in Postmenopausal Women Who Participated in the
FREEDOM Trial. Michael C. Nevitt 11 , Stuart L. Silverman 3 , Hema
Viswanathan 1 , Yu-Ching Yang 1 , Andrea Wang 1 , Steven Boonen 2 ,
Sergio Ragi-Eis 4 , Patrice Fardellone 9 , Andreas Grauer 1 , Nigel
Gilchrist 5 , Paul Lips 12 , Santiago Palacios 8 , Karel Pavelka 6 , Dennis
Revicki 10 , James Simon 13 , David Macarios 1 and Ethel Siris 7 ,
1
Amgen Inc., Thousand Oaks, CA, 2 Bone Research Unit, Leuven
University, Leuven, Belgium, 3 Cedars-Sinai Medical Center,
University of California Los Angeles, Beverly Hills, CA, 4 CEDOES
Diagnóstico e Pesquisa, Vitória (ES), Brazil, 5 CGM Research
Trust and Canterbury District Health Board, Christchurch, New
Zealand, 6 Charles University, Prague, Czech Republic, 7 Columbia
University Medical Center, New York, NY, 8 Palacios Institute of
Woman’s Health, Madrid, Spain, 9 Service de Rhumatologie,
Hôpital Nord, INSERM ERI 12, Amiens, France, 10 United
BioSource Corporation, Bethesda, MD, 11 University of California
San Francisco, San Francisco, CA, 12 VU University Medical
Center, Amsterdam, The Netherlands, 13 Women’s Health &
Research Consultants®, Washington, DC.
972. Incidence of Low Energy Hip Fracture in Southern Norway
Significantly Lower Than Reported from the Capital of Norway
(Oslo). Andreas Diamantopoulos 1 , Gudrun Rohde 2 , Irene
Johnsrud 1 , Inger Marie Skoie 1 , Villy Johnsen 1 , Marc C. Hochberg 3
and Glenn Haugeberg 1 , 1 Department of Rheumatology,
Soerlandet Hospital SSHF, Kristiansand, Norway, 2 Faculty of
Health and Sport, University of Agder, Kristiansand, Norway,
3
University of Maryland, Baltimore, MD.
973. Increases in Macrophage Inhibitory Factor Correlate with
Increases in Bone Mineral Density in Glucocorticoid-Treated
Patients with RA. Jos Nicolaas Hoes 1 , Marlies C. Van der Goes 2 ,
Johannes W. G. Jacobs 2 , Johannes W. J. Bijlsma 2 and Joel A. G.
Van Roon 2 , 1 University Medical Center Utrecht, Department
of Rheumatology & Clinical Immunology, Utrecht, The
Netherlands, 2 University Medical Center Utrecht, Department of
Rheumatology & Clinical Immunology.
974. Low Bone Mineral Density in Depoprovera Users – An Under
Recognised Health Issue. Mani Nallasivan 1 and Tim Gillott 2 ,
1
Diana Princess of Wales Hospital, Northern Lincolnshire and
Goole Hospitals NHS Trust, Hull, Yorkshire, United Kingdom,
2
Diana Princess of Wales Hospital, Northern Lincolnshire and
Goole Hospitals NHS Trust, Grimsby, Northeast Lincolnshire,
United Kingdom.
975. National Registry of Paget Disease of Bone. Estibaliz Loza, Nuria
Guañabens, Maria Jesus Garcia de Yebenes, Antonio Morales,
Javier Del Pino, Antonio Torrijos, Jesus Garrido, Jesus Tornero,
Jorge Malouf, Jordi Carbonell and Manuel Rodriguez, Spanish
Society of Rheumatology.
976. Prevalence of Osteoporosis and Osteoporotic Fractures:
A Population Based Survey Including Vertebral Fracture
Assessment by Morphometry (VFA). Liana E. Euller-Ziegler 1 ,
Christian H. Roux 1 , Veronique Breuil 1 , Virginie Dasilva 1 , Christine
Albert-Sabonnadiere 1 , Christian Grisot 1 , Philippe Flory 1 , Yacine
Allam 1 , Hasna Chami 1 , Gerard Ziegler 1 and Pascal Staccini 2 ,
1
L’Archet Hospital, University of Nice, Nice, France, 2 Labstic
Santé, University of Nice, Nice, France.
977. Proactively Contacting Men with Prostate Cancer Treated
with Anti-Androgen Medications Improves the Evaluation and
Treatment of Osteoporosis. Brian P. Oppermann 1 , Thomas M.
Harrington 2 and William Ayoub 3 , 1 Geisinger Medical Center,
Danville, PA, 2 Geisinger Medical Center, Danville PA, 3 Geisinger
Medical Group, Scenary Park PA.
978. Quality Assurance Study of the Use of Preventative Therapies
in Glucocorticord Induced Osteoporosis (GIOP) in Early
Inflammatory Arthritis (EIA): Results from the CATCH Cohort.
Emily McKeown 10 , Vivian P. Bykerk 5 , Faye Deleon 4 , J. Carter
Thorne 6 , Carol A. Hitchon 8 , Gilles Boire 2 , Boulos Haraoui 3 ,
Diane S. Ferland 1 , Ed C. Keystone 9 and Janet E. Pope 7 , 1 LaSalle,
QC, Canada, 2 CHUS - Sherbrooke University, Sherbrooke, QC,
Canada, 3 Institut de Rhumatologie, Montreal, QC, Canada,
4
McMaster University, Hamilton, ON, Canada, 5 Mt Sinai
Hospital, Toronto, ON, Canada, 6 Southlake Regional Health
Care, Newmarket, ON, Canada, 7 St Joseph Health Care London,
London, ON, Canada, 8 University of Manitoba, Winnipeg,
MB, Canada, 9 University of Toronto, Toronto, ON, Canada,
10
University of Western Ontario, London, ON, Canada.
979. Relationships between Changes in Bone Mineral Density or
Bone Turnover Markers and Vertebral Fractures Incidence
in Patients Treated with Bazedoxifene. Olivier Bruyere 2 ,
Johann Detilleux 3 , Arkadi Chines 1 and Jean Y. Reginster 2 , 1 Pfizer,
2
University of Liege, Liege, Belgium, 3 University of Liege.
2010 Program Book 207